Kinnate Biopharma Inc. (KNTE) Tops Q2 EPS by 7c

Kinnate Biopharma Inc. (NASDAQ: KNTE) reported Q2 EPS of ($0.68), $0.07 better than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Kinnate Biopharma Inc. (KNTE) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BofA Securities Reiterates Buy Rating on NVIDIA (NVDA)
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24